RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017

Oct 4, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04

Reporting Person: PFIZER INC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$0		Common Stock (447514)		Direct
Series A-1 Junior Preferred Stock	$0		Common Stock (940125)		Direct

Footnotes

F1: At any time at the Reporting Person's election or upon the closing of the Issuer's initial public offering (the "IPO"), each share of the Issuer's series A convertible preferred stock (the "Series A Preferred") and series A-1 junior preferred stock (the "Series A-1 Preferred") is convertible into shares of the Issuer's common stock on a 9.17-for-one basis without payment or consideration. The Series A Preferred and the Series A-1 Preferred have no expiration date.